カルナバイオサイエンスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/10/12 | 1,070 | 1,070 | 1,038 | 1,043 | -21 | -2% | 40,600 |
2021/10/11 | 1,059 | 1,068 | 1,046 | 1,064 | +10 | +0.9% | 32,100 |
2021/10/08 | 1,050 | 1,062 | 1,050 | 1,054 | +7 | +0.7% | 36,000 |
2021/10/07 | 1,050 | 1,058 | 1,036 | 1,047 | -4 | -0.4% | 38,000 |
2021/10/06 | 1,059 | 1,075 | 1,041 | 1,051 | -14 | -1.3% | 58,800 |
2021/10/05 | 1,063 | 1,078 | 1,037 | 1,065 | -14 | -1.3% | 73,300 |
2021/10/04 | 1,115 | 1,115 | 1,067 | 1,079 | -13 | -1.2% | 46,400 |
2021/10/01 | 1,090 | 1,099 | 1,077 | 1,092 | -7 | -0.6% | 46,700 |
2021/09/30 | 1,109 | 1,109 | 1,083 | 1,099 | +10 | +0.9% | 31,900 |
2021/09/29 | 1,082 | 1,095 | 1,050 | 1,089 | -4 | -0.4% | 70,500 |
2021/09/28 | 1,090 | 1,093 | 1,082 | 1,093 | -6 | -0.5% | 35,000 |
2021/09/27 | 1,135 | 1,135 | 1,090 | 1,099 | -20 | -1.8% | 58,600 |
2021/09/24 | 1,099 | 1,133 | 1,099 | 1,119 | +42 | +3.9% | 131,400 |
2021/09/22 | 1,095 | 1,103 | 1,077 | 1,077 | -25 | -2.3% | 73,300 |
2021/09/21 | 1,085 | 1,104 | 1,075 | 1,102 | +5 | +0.5% | 52,200 |
2021/09/17 | 1,096 | 1,116 | 1,082 | 1,097 | -1 | -0.1% | 133,700 |
2021/09/16 | 1,137 | 1,144 | 1,085 | 1,098 | -43 | -3.8% | 121,500 |
2021/09/15 | 1,160 | 1,161 | 1,135 | 1,141 | -19 | -1.6% | 128,000 |
2021/09/14 | 1,180 | 1,181 | 1,155 | 1,160 | -24 | -2% | 114,800 |
2021/09/13 | 1,190 | 1,190 | 1,179 | 1,184 | -9 | -0.8% | 55,000 |
2021/09/10 | 1,188 | 1,198 | 1,188 | 1,193 | +3 | +0.3% | 44,100 |
2021/09/09 | 1,192 | 1,214 | 1,188 | 1,190 | -7 | -0.6% | 80,200 |
2021/09/08 | 1,190 | 1,198 | 1,188 | 1,197 | +2 | +0.2% | 92,000 |
2021/09/07 | 1,197 | 1,197 | 1,188 | 1,195 | +4 | +0.3% | 49,100 |
2021/09/06 | 1,198 | 1,199 | 1,188 | 1,191 | -7 | -0.6% | 35,300 |
2021/09/03 | 1,197 | 1,202 | 1,189 | 1,198 | +1 | +0.1% | 26,800 |
2021/09/02 | 1,211 | 1,212 | 1,192 | 1,197 | -14 | -1.2% | 43,500 |
2021/09/01 | 1,201 | 1,212 | 1,190 | 1,211 | +10 | +0.8% | 54,200 |
2021/08/31 | 1,203 | 1,215 | 1,195 | 1,201 | -4 | -0.3% | 40,100 |
2021/08/30 | 1,200 | 1,205 | 1,191 | 1,205 | +7 | +0.6% | 32,900 |
2021/08/27 | 1,197 | 1,209 | 1,192 | 1,198 | -5 | -0.4% | 24,600 |
2021/08/26 | 1,199 | 1,209 | 1,198 | 1,203 | +3 | +0.3% | 25,200 |
2021/08/25 | 1,201 | 1,214 | 1,196 | 1,200 | -9 | -0.7% | 27,400 |
2021/08/24 | 1,205 | 1,209 | 1,195 | 1,209 | +7 | +0.6% | 27,700 |
2021/08/23 | 1,207 | 1,232 | 1,201 | 1,202 | -7 | -0.6% | 50,300 |
2021/08/20 | 1,219 | 1,231 | 1,187 | 1,209 | -13 | -1.1% | 89,900 |
2021/08/19 | 1,258 | 1,264 | 1,222 | 1,222 | -36 | -2.9% | 64,000 |
2021/08/18 | 1,243 | 1,267 | 1,230 | 1,258 | +15 | +1.2% | 47,700 |
2021/08/17 | 1,263 | 1,268 | 1,235 | 1,243 | -28 | -2.2% | 66,900 |
2021/08/16 | 1,275 | 1,278 | 1,259 | 1,271 | -1 | -0.1% | 29,900 |
2021/08/13 | 1,260 | 1,295 | 1,260 | 1,272 | +6 | +0.5% | 29,900 |
2021/08/12 | 1,308 | 1,308 | 1,265 | 1,266 | -26 | -2% | 56,500 |
2021/08/11 | 1,309 | 1,309 | 1,282 | 1,292 | -10 | -0.8% | 50,300 |
2021/08/10 | 1,270 | 1,302 | 1,270 | 1,302 | +30 | +2.4% | 45,900 |
2021/08/06 | 1,272 | 1,313 | 1,260 | 1,272 | -15 | -1.2% | 68,900 |
2021/08/05 | 1,280 | 1,309 | 1,259 | 1,287 | +7 | +0.5% | 67,600 |
2021/08/04 | 1,302 | 1,315 | 1,280 | 1,280 | -29 | -2.2% | 66,100 |
2021/08/03 | 1,282 | 1,349 | 1,282 | 1,309 | +26 | +2% | 117,400 |
2021/08/02 | 1,238 | 1,297 | 1,235 | 1,283 | +73 | +6% | 80,000 |
2021/07/30 | 1,243 | 1,243 | 1,205 | 1,210 | -19 | -1.5% | 62,700 |
751~
800
件表示中 / 3572件
類似銘柄と比較する
現在ご覧いただいている「カルナバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
カルナバイオ | 30,400円 | -43.1% | - | 0.00% | - | 1.81倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
カイオム | 9,900円 | +2.6% | - | 0.00% | - | 5.73倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
VIS | 91,000円 | +87.8% | +265.7% | 0.00% | 54.65倍 | 2.51倍 |
|
mRNA標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
クリングル | 82,300円 | +14.5% | - | 0.00% | - | 2.43倍 |
|
細胞の増殖、保護、修復などの機能があるHGFタンパク質を用いて、難治性疾患治療薬を開発 |
DELTA-P | 65,800円 | - | - | 0.00% | - | 4.40倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
市場注目の銘柄
チャート関連のコラム